Autologous Serum Eye Drops in Dry Eye Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorThe General Authority for Teaching Hospitals and Institutes
About this trial
This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.
Eligibility criteria
Qualifiers
Children aged less than 18 years.
Both sexes.
Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.
Disqualifiers
Active ocular infection.
Recent ocular surgery.
Systemic immunosuppressive therapy.
History of allergy to blood-derived products.
Trial design
Treatments tested in this trial
- Autologous Serum Eye Drop
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov